Country Profile

Somalia

Somalia is a growing market for Indian pharmaceuticals — $60.0M in FY 2025–26, with 7.1× growth over the past decade. Medicines accounts for 82% of shipments, with vaccines contributing $9.38M. The compound annual growth rate since FY2015 stands at 19.5%.

🇸🇴 $60.0M · 7.1× growth since FY2015 · 19.5% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$60.0M
Exports FY2025–26 DGCIS
7.1×
Growth FY2015→2026
19.5%
CAGR FY2015→2026
82%
Medicines Share
5
Product Categories Supplied
Somalia is a growing market for Indian pharmaceuticals — $60.0M in FY 2025–26, with 7.1× growth over the past decade. Medicines accounts for 82% of shipments, with vaccines contributing $9.38M. The compound annual growth rate since FY2015 stands at 19.5%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $49.1M (81.8%) Vaccines $9.38M (15.6%) Surgical & Hospital Supplies $1.24M (2.1%) Traditional & Herbal $263K (0.4%) Medicine Ingredients $27K (0.0%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Somalia in the RBI overseas direct investment dataset (2011–2026).